Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2017 | 07-2016 | 07-2015 | 07-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,581 | -7,814 | -7,038 | -11,483 | N/A |
| Depreciation Amortization | 5 | 2 | 1 | 134 | 130 |
| Accounts receivable | -3,438 | -313 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,071 | -175 | 115 | 160 | N/A |
| Other Working Capital | -2,727 | -4,764 | 1,068 | 1,120 | 60 |
| Other Operating Activity | 3,063 | 12,148 | 1,614 | 9,064 | 1,230 |
| Operating Cash Flow | $5,556 | $-915 | $-4,239 | $-1,005 | $1,420 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -8 | N/A | N/A | 0 |
| Investing Cash Flow | $N/A | $-8 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 151 | N/A | N/A | N/A |
| Other Financing Activity | -165 | 1,819 | 4,419 | 662 | 0 |
| Financing Cash Flow | $-165 | $1,970 | $4,419 | $662 | $N/A |
| Beginning Cash Position | 1,481 | 434 | 255 | 599 | N/A |
| End Cash Position | 6,873 | 1,481 | 434 | 255 | N/A |
| Net Cash Flow | $5,391 | $1,047 | $179 | $-344 | $1,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,556 | -915 | -4,239 | -1,005 | 1,420 |
| Capital Expenditure | N/A | -8 | N/A | N/A | N/A |
| Free Cash Flow | 5,556 | -923 | -4,239 | -1,005 | 1,420 |